FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
Fiche publication
Date publication
février 2017
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier, Dr RETIF Paul
Tous les auteurs :
Huertas A, Oldrini S, Nesseler JP, Courrech F, Rétif P, Charra-Brunaud C, Peiffert D
Lien Pubmed
Résumé
The treatment of cervical cancers according to FIGO staging is well defined. For FIGO stage IB2 or more, chemoradiotherapy followed by uterovaginal brachytherapy boost is the standard treatment. Surgery is the preferred choice for less advanced tumors. However, most French institutions propose preoperative brachytherapy followed by hysterectomy with pelvic lymphadenectomy for FIGO stage IB1 tumors over 2cm. Brachytherapy is also used for the boost after adjuvant pelvic external beam radiotherapy. Tridimensional dosimetry with optimization allows better treatment planning, delivering high doses to target volumes with limited irradiation to the organs at risk. We will discuss the indications of brachytherapy for FIGO stage IB1 tumors and the principles of pulsed-dose rate and high-dose rate techniques.
Mots clés
Brachytherapy, Cancer du col utérin, Cervical cancer, Colpohystérectomie, Curiethérapie, HDR, Hysterectomy, Optimization, PDR
Référence
Cancer Radiother. 2017 Feb;: